Author details

Full Name

Scott M Grundy

Affiliation

ORCID

Career Start Year

1958

Papers

729

H Index

166

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36608437	Is There a Role for Coronary Calcium in Patients With Diabetes?		2023
36593174	Statin therapy for primary prevention in men: What is the role for coronary artery calcium?		2023
36495681	Risk Enhancing Factors and Coronary Artery Calcium Strengthen Atherosclerotic Cardiovascular Disease Risk Estimation.	Am J Cardiol	2023
34717898	Statin Intolerance and Noncompliance: An Empiric Approach.	American Journal of Medicine	2022
35998005	Statin Usage in Primary Prevention-Comparing the USPSTF Recommendations With the AHA/ACC/Multisociety Guidelines.	JAMA Cardiol	2022
35614000	Statin therapy for primary prevention in women: What is the role for coronary artery calcium?	Journal of Clinical Lipidology	2022
36395880	Guidelines for the management of hyperlipidemia: How can clinicians effectively implement them?	Prog Cardiovasc Dis	2022
34922882	Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease.	Journal of Clinical Lipidology	2022
35210038	Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review.	J Am Coll Cardiol	2022
34531060	High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better.	Mayo Clin Proc	2021
34019857	Coronary Artery Calcium: Where Do We Stand After Over 3 Decades?	Am J Med	2021
33663990	Utility of metabolic syndrome as a risk enhancing factor in decision of statin use.	Journal of Clinical Lipidology	2021
33191195	Chronic kidney disease and statin eligibility.	Journal of Clinical Lipidology	2021
34371083	Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.	Prog Cardiovasc Dis	2021
32669405	The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes.	Diabetes Care	2020
32250697	Comparing Primary Prevention Recommendations: A Focused Look at United States and European Guidelines on Dyslipidemia.	Circulation	2020
32250694	Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia.	Circulation	2020
32467016	Temporal decline in non-high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease.	Journal of Clinical Lipidology	2020
33309175	Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.	J Am Coll Cardiol	2020
30994869	2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention.	JAMA Cardiol	2019
31733217	The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and future.	Prog Cardiovasc Dis	2019
30586774	2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.	Circulation	2019
30423393	2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association TaskÂ ForceÂ onÂ Clinical Practice Guidelines.	J Am Coll Cardiol	2019
30423391	2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association TaskÂ ForceÂ onÂ Clinical Practice Guidelines.	J Am Coll Cardiol	2019
30565953	2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.	Circulation	2019
31229022	Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines.	J Clin Lipidol	2019
31132793	2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.	Ann Intern Med	2019
30969322	2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention.	JAMA Cardiol	2019
30969319	Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol.	JAMA Cardiol	2019
31429891	Treating Hypercholesterolemia in Older Adults.	JAMA	2019
31370962	Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018Â AHA/ACC Cholesterol Guidelines.	J Am Coll Cardiol	2019
31248654	Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease.	Journal of Clinical Lipidology	2019
29682733	Upper body fat predicts metabolic syndrome similarly in men and women.	European Journal of Clinical Investigation	2018
30571575	Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.	Circulation	2018
28291590	An Analysis of Individual Body Fat Depots and Risk of Developing Cancer: Insights From the Dallas Heart Study.	Mayo Clinic Proceedings	2017
29264465	Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome.	Journal of the Endocrine Society	2017
27673306	Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.	JAMA	2016
27194746	Overnutrition, ectopic lipid and the metabolic syndrome.	Journal of Investigative Medicine	2016
27428873	Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study.	Nutrition and Diabetes	2016
27055958	Fatty acid oxidation in normotriglyceridemic men.	Journal of Clinical Lipidology	2016
27166935	Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate.		2016
26763537	Dyslipidaemia in 2015: Advances in treatment of dyslipidaemia.	Nature Reviews Cardiology	2016
26654259	Metabolic syndrome update.	Trends in Cardiovascular Medicine	2016
27739004	Does Dietary Cholesterol Matter?	Current Atherosclerosis Reports	2016
27919359	Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men.	Journal of Clinical Lipidology	2016
26699442	National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.	J Clin Lipidol	2015
25551401	Is There a Gradient of Mortality Risk among Men with Low Cardiorespiratory Fitness?	Medicine and Science in Sports and Exercise	2015
25911072	National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.	Journal of Clinical Lipidology	2015
25572522	Reply: statin-induced low low-density lipoprotein cholesterol level: is lower better?	Journal of the American College of Cardiology	2015
25677443	Reply: Statin dose based on limited evidence.	Journal of the American College of Cardiology	2015